Jerry Muhammad
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- HIV/AIDS drug development and treatment 2
-
- Biochemical and Molecular Research 1
- Co-authors
- Ben S. Zweifel (2 shared papers)Jaime L. Masferrer (2 shared papers)Karen Seibert (2 shared papers)Peter C. Isakson (2 shared papers)Carol M. Koboldt (2 shared papers)Yan Zhang (2 shared papers)Chris Smith (1 shared paper)John J. Talley (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Antiviral Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Jerry Muhammad
5 papers receiving 835 citations
Jerry Muhammad's Hit Papers
Peers
Comparison fields: 5 of 85
- Pharmacology 522
- Biochemistry 153
- Pharmacology 75
- Hepatology 50
- Cellular and Molecular Neuroscience 112
Countries citing papers authored by Jerry Muhammad
This map shows the geographic impact of Jerry Muhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Muhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Muhammad more than expected).
Fields of papers citing papers by Jerry Muhammad
This network shows the impact of papers produced by Jerry Muhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Muhammad. The network helps show where Jerry Muhammad may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerry Muhammad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological analysis of cyclooxygenase-1 in inflammation Hit paper breakdown → | 1998 | 713 |
| 2 | 2010 | 73 | |
| 3 | 2005 | 72 | |
| 4 | 2010 | 12 | |
| 5 | 2009 | 2 |
About Jerry Muhammad
Jerry Muhammad is a scholar working on Infectious Diseases, Molecular Biology, Pharmacology, Genetics and Hepatology, having authored 5 papers that have together received 872 indexed citations. Recurring topics across this work include Hepatitis C virus research (2 papers), Estrogen and related hormone effects (2 papers), HIV/AIDS drug development and treatment (2 papers), Inflammatory mediators and NSAID effects (2 papers), Hepatitis B Virus Studies (1 paper), Pain Mechanisms and Treatments (1 paper), Biochemical and Molecular Research (1 paper) and Neuropeptides and Animal Physiology (1 paper). The work is most often cited by research in Pharmacology (522 citations), Biochemistry (153 citations), Pharmacology (75 citations), Hepatology (50 citations) and Cellular and Molecular Neuroscience (112 citations). Jerry Muhammad has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Ben S. Zweifel, Jaime L. Masferrer, Karen Seibert, Peter C. Isakson, Carol M. Koboldt, Yan Zhang, Chris Smith, John J. Talley, Jennifer S. Trigg and Mark C. Walker. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Antiviral Research, Proceedings of the National Academy of Sciences and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.